Insider Trading History of Nougues Maximo F

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Nougues Maximo F since 2021. This trader's CIK number is 1758507. At the time of last reporting, Nougues Maximo F was the Chief Financial Officer of Puma Biotechnology, Inc.. (stock ticker symbol PBYI). Also see all insider trading activities at Puma Biotechnology, Inc..


Yearly summary of insider trading at Puma Biotechnology, Inc. (PBYI) by Nougues Maximo F

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 PBYI 0 $0 19,749 $65,883 0 $0
2024 PBYI 0 $0 25,133 $103,039 0 $0
2023 PBYI 0 $0 14,680 $48,605 0 $0
2022 PBYI 0 $0 15,039 $43,424 0 $0
2021 PBYI 0 $0 3,728 $34,828 0 $0


Insider trading of Puma Biotechnology, Inc. (PBYI) by Nougues Maximo F

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-09 PBYI Sale 3,935 3.54 13,910
2025-07-08 PBYI Sale 5,587 3.53 19,738
2025-01-02 PBYI Sale 10,227 3.15 32,235
2024-07-17 PBYI Sale 4,156 3.70 15,381
2024-07-02 PBYI Sale 5,295 3.27 17,309
2024-01-03 PBYI Sale 15,682 4.49 70,349
2023-07-03 PBYI Sale 14,680 3.31 48,605
2022-11-02 PBYI Sale 163 2.25 366
2022-10-03 PBYI Sale 165 2.33 385
2022-08-02 PBYI Sale 161 2.89 465
2022-07-05 PBYI Sale 5,835 2.63 15,357
2022-06-02 PBYI Sale 162 1.92 311
2022-05-03 PBYI Sale 165 2.34 386
2022-05-03 PBYI Sale 165 2.34 386
2022-05-03 PBYI Sale 165 2.34 386
2022-04-04 PBYI Sale 206 3.08 634
2022-03-02 PBYI Sale 169 2.26 382
2022-02-02 PBYI Sale 199 2.48 493
2022-01-03 PBYI Sale 7,484 3.19 23,873
2021-12-02 PBYI Sale 162 2.95 477
2021-11-02 PBYI Sale 156 5.67 884
2021-10-04 PBYI Sale 161 6.20 998
2021-09-02 PBYI Sale 155 7.51 1,164
2021-08-02 PBYI Sale 154 7.54 1,161
2021-07-02 PBYI Sale 155 9.26 1,435
2021-05-03 PBYI Sale 152 9.91 1,506
2021-04-05 PBYI Sale 155 9.80 1,519
2021-03-02 PBYI Sale 154 10.14 1,560
2021-02-02 PBYI Sale 179 12.26 2,194
2021-01-04 PBYI Sale 2,145 10.22 21,930

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nougues Maximo F (Chief Financial Officer of Puma Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.